Clinical Trial Update: NAC for Treating Comorbid PTSD and SUD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating N-acetylcysteine (NAC) for comorbid PTSD and substance use disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Posttraumatic Stress Disorder
• Substance Use Disorder

Drugs mentioned

• N-acetylcysteine (NAC) (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Posttraumatic Stress Disorder (PTSD), Alcohol Use Disorder (AUD) | Phase 2 | Status: COMPLETED | Results posted: 2021-05-19